EcoDrugPlus

Eph Receptor A2

Ensembl ID : ENSSVLG00005000603
Gene Symbol: EPHA2
1 Cross references
124 Possible Orthologues:

Eph Receptor A3

Ensembl ID : ENSSVLG00005012314
Gene Symbol: EPHA3
1 Cross references
215 Possible Orthologues:

Eph Receptor B4

Ensembl ID : ENSSVLG00005025419
Gene Symbol: EPHB4
1 Cross references
166 Possible Orthologues:

F2r Like Thrombin Or Trypsin Receptor 3

Ensembl ID : ENSSVLG00005023189
Gene Symbol: F2RL3
1 Cross references
197 Possible Orthologues:

Fxyd Domain Containing Ion Transport Regulator 2

Ensembl ID : ENSSVLG00005023606
Gene Symbol: FXYD2
1 Cross references
74 Possible Orthologues:

Fyn Proto-Oncogene, Src Family Tyrosine Kinase

Ensembl ID : ENSSVLG00005010663
Gene Symbol: FYN
1 Cross references
261 Possible Orthologues:

G Protein-Coupled Receptor 119

Ensembl ID : ENSSVLG00005017240
Gene Symbol: GPR119
1 Cross references
174 Possible Orthologues:

G Protein-Coupled Receptor 84

Ensembl ID : ENSSVLG00005000857
Gene Symbol: GPR84
1 Cross references
124 Possible Orthologues:

Hck Proto-Oncogene, Src Family Tyrosine Kinase

Ensembl ID : ENSSVLG00005001700
Gene Symbol: HCK
1 Cross references
205 Possible Orthologues:

Il2 Inducible T Cell Kinase

Ensembl ID : ENSSVLG00005013116
Gene Symbol: ITK
1 Cross references
207 Possible Orthologues:

Janus Kinase 1

Ensembl ID : ENSSVLG00005010529
Gene Symbol: JAK1
1 Cross references
236 Possible Orthologues:

Janus Kinase 2

Ensembl ID : ENSSVLG00005024808
Gene Symbol: JAK2
1 Cross references
265 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).